GSK Investigational Site

Mayfield Heights, Ohio 44124

0 studies enrolling now · 5 studies all time

What they study most

Hypereosinophilic Syndrome, Neoplasms, Ovarian, Ovarian Cancer, Thrombocytopaenia

Studies at this site

• A Multi-center, Open-label Extension, Safety Study of Mepolizumab in Subjects With Hypereosinophilic Syndrome (HES) From Study 200622 — Completed
• Efficacy and Safety Study of Mepolizumab in Subjects With Severe Hypereosinophilic Syndrome (HES) — Completed
• SB-497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adult Cancer Patients Receiving Chemotherapy — Completed
• Second-Line Therapy Study For Potentially Platinum-Sensitive Relapsed Ovarian Cancer — Completed
• Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer — Completed